Atlas Trials

Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.

Clinical trial NCT04353193 · UNKNOWN

Trial details

NCT number
NCT04353193
Sponsor
Juan A. Arnaiz
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Liver Cirrhosis Portal
Start date
2020-06-01
Primary completion
2022-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.